Bacopa monnieri inhibit hen egg white lysozyme fibrillation and help in retaining its activity at acidic condition

References

• Ajmal, M. R., Chaturvedi, S. K., Zaidi, N., Alam, P., Zaman, M., Siddiqi, M. K., … Khan, R. H. (2017). Biophysical insights into the interaction of hen egg white lysozyme with therapeutic dye clofazimine: modulation of activity and SDS induced aggregation of model protein. Journal of Biomolecular Structure and Dynamics, 35(10), 2197–2210. doi: 10.1080/07391102.2016.1211552
   PubMed Web of Science ®Google Scholar
• Al-Shabib, N. A., Khan, J. M., Malik, A., Sen, P., Alsenaidy, M. A., Husain, F. M., … Shahzad, S. A. (2019). A quercetin-based flavanoid (rutin) reverses amyloid fibrillation in β-lactoglobulin at pH2.0 and 358 K. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 214, 40–48. doi: 10.1016/j.saa.2019.02.004
   PubMed Web of Science ®Google Scholar
• Alam, P., Chaturvedi, S. K., Siddiqi, M. K., Rajpoot, R. K., Ajmal, M. R., Zaman, M., & Khan, R. H. (2016). Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. Scientific Reports, 6, 26759. doi: 10.1038/srep26759
   PubMed Web of Science ®Google Scholar
• Arnaudov, L. N., & de Vries, R. (2005). Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophysical Journal, 88(1), 515–526. doi: 10.1529/biophysj.104.048819
   PubMed Web of Science ®Google Scholar
• Blanco, E., Ruso, J. M., Sabín, J., Prieto, G., & Sarmiento, F. (2007). Thermalstability of lysozyme and myoglobin in the presence of anionic surfactants. Journal of Thermal Analysis and Calorimetry, 87(1), 211–215. doi: 10.1007/s10973-006-7842-5
   Web of Science ®Google Scholar
• Brudar, S., & Hribar-Lee, B. (2019). The role of buffers in wild-type HEWL amyloid fibril formation mechanism. Biomolecules, 9(2), 65. doi: 10.3390/biom9020065
   PubMed Web of Science ®Google Scholar
• Caldarini, M., Vasile, F., Provasi, D., Longhi, R., Tiana, G., & Broglia, R. A. (2009). Identification and characterization of folding inhibitors of hen egg lysozyme: An example of a new paradigm of drug design. Proteins: Structure, Function, and Bioinformatics, 74(2), 390–399. doi: 10.1002/prot.22161
   PubMed Web of Science ®Google Scholar
• Chaari, A., Fahy, C., Chevillot-Biraud, A., & Rholam, M. (2015). Insights into kinetics of agitation-induced aggregation of hen lysozyme under heat and acidic conditions from various spectroscopic methods. PLos One, 10(11), e0142095. doi: 10.1371/journal.pone.0142095
   PubMed Web of Science ®Google Scholar
• Chaturvedi, S. K., Zaidi, N., Alam, P., Khan, J. M., Qadeer, A., Siddique, I. A., … Khan, R. H. (2015). Unraveling comparative anti-amyloidogenic behavior of pyrazinamide and D-cycloserine: A mechanistic biophysical insight. PLos One, 10(8), e0136528. doi: 10.1371/journal.pone.0136528
   PubMed Web of Science ®Google Scholar
• Chiti, F., & Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annual Review of Biochemistry, 75(1), 333–366. doi: 10.1146/annurev.biochem.75.101304.123901
   PubMed Web of Science ®Google Scholar
• Chiti, F., & Dobson, C. M. (2017). Protein misfolding, amyloid formation, and human disease: A summary of progress over the last decade. Annual Review of Biochemistry, 86, 27–68. doi: 10.1146/annurev-biochem-061516-045115
   PubMed Web of Science ®Google Scholar
• Dash, B., & Kashyap, L. (1980). Materia medica of Ayurveda based on Ayurveda Saukhyam of Todaranânda. New Delhi: Concept Publishing Company.
   Google Scholar
• Davies, R., Neuberger, A., & Wilson, B. (1969). The dependence of lysozyme activity on pH and ionic strength. Biochimica et Biophysica Acta (BBA) Enzymology, 178(2), 294–305. doi: 10.1016/0005-2744(69)90397-0
   PubMedGoogle Scholar
• Deepak, M., & Amit, A. (2004). The need for establishing identities of ‘bacoside A and B’, the putative major bioactive saponins of Indian medicinal plant Bacopa monnieri. Phytomedicine, 11(2), 264–268. doi: 10.1078/0944-7113-00351
   PubMed Web of Science ®Google Scholar
• Deo, Y. K., & Reddy, K. (2013). Critical review on pharmacological properties of Brahmi. International Journal of Ayurvedic Medicine, 4(2), 92–99.
   Google Scholar
• Dhanasekaran, M., Tharakan, B., Holcomb, L. A., Hitt, A. R., Young, K. A., & Manyam, B. V. (2007). Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytotherapy Research, 21(10), 965–969. doi: 10.1002/ptr.2195
   PubMed Web of Science ®Google Scholar
• Eisele, Y. S., Monteiro, C., Fearns, C., Encalada, S. E., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2015). Targeting protein aggregation for the treatment of degenerative diseases. Nature Reviews Drug Discovery, 14(11), 759. doi: 10.1038/nrd4593
   PubMed Web of Science ®Google Scholar
• Eisenberg, D., & Jucker, M. (2012). The amyloid state of proteins in human diseases. Cell, 148(6), 1188–1203. doi: 10.1016/j.cell.2012.02.022
   PubMed Web of Science ®Google Scholar
• Esteras-Chopo, A., Pastor, M. T., Serrano, L., & López de la Paz, M. (2008). New strategy for the generation of specific D-peptide amyloid inhibitors. Journal of Molecular Biology, 377(5), 1372–1381. doi: 10.1016/j.jmb.2008.01.028
   PubMed Web of Science ®Google Scholar
• Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297(5580), 353–356. doi: 10.1126/science.1072994
   PubMed Web of Science ®Google Scholar
• Hill, S. E., Robinson, J., Matthews, G., & Muschol, M. (2009). Amyloid protofibrils of lysozyme nucleate and grow via oligomer fusion. Biophysical Journal, 96(9), 3781–3790. doi: 10.1016/j.bpj.2009.01.044
   PubMed Web of Science ®Google Scholar
• Holcomb, L. A., Dhanasekaran, M., Hitt, A. R., Young, K. A., Riggs, M., & Manyam, B. V. (2006). Bacopa monniera extract reduces amyloid levels in PSAPP mice. Journal of Alzheimer's Disease, 9(3), 243–251. doi: 10.3233/JAD-2006-9303
   PubMed Web of Science ®Google Scholar
• Imoto, T., Andrews, L. J., Banerjee, S. K., Shrake, A., Forster, L. S., & Rupley, J. A. (1975). Optical properties of lysozyme. pH and saccharide binding difference spectra. Journal of Biological Chemistry, 250(20), 8275–8282.
   PubMed Web of Science ®Google Scholar
• Imoto, T., Johnson, L., North, A., Phillips, D., & Rupley, J. (1972). Vertebrate Lysozymes. In P. D. Boyer (Ed.), The enzymes (Vol. 7, 3rd ed., pp. 665–868). New York, NY: Academic Press, Inc.
   Google Scholar
• Jadiya, P., Khan, A., Sammi, S. R., Kaur, S., Mir, S. S., & Nazir, A. (2011). Anti-Parkinsonian effects of Bacopa monnieri: Insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s disease. Biochemical and Biophysical Research Communications, 413(4), 605–610. doi: 10.1016/j.bbrc.2011.09.010
   PubMed Web of Science ®Google Scholar
• Janin, J., & Wodak, S. J. (1983). Structural domains in proteins and their role in the dynamics of protein function. Progress in Biophysics and Molecular Biology, 42, 21–78. doi: 10.1016/0079-6107(83)90003-2
   PubMed Web of Science ®Google Scholar
• Jash, C., & Kumar, G. S. (2014). Binding of alkaloids berberine, palmatine and coralyne to lysozyme: A combined structural and thermodynamic study. RSC Advances, 4(24), 12514–12525. doi: 10.1039/c3ra46053c
   Web of Science ®Google Scholar
• Jeong, J. H., Jeong, H. R., Jo, Y. N., Kim, H. J., Shin, J. H., & Heo, H. J. (2013). Ameliorating effects of aged garlic extracts against Abeta-induced neurotoxicity and cognitive impairment. BMC Complementary and Alternative Medicine, 13, 268. doi: 10.1186/1472-6882-13-268
   PubMed Web of Science ®Google Scholar
• Khan, A. Y., & Suresh Kumar, G. (2018). Exploring the binding interaction of potent anticancer drug topotecan with human serum albumin: Spectroscopic, calorimetric and fibrillation study. Journal of Biomolecular Structure and Dynamics, 36(9), 2463–2473. doi: 10.1080/07391102.2017.1359671
   PubMed Web of Science ®Google Scholar
• Khan, J. M., Khan, M. R., Sen, P., Malik, A., Irfan, M., & Khan, R. H. (2018). An intermittent amyloid phase found in gemini (G5 and G6) surfactant induced β-sheet to α-helix transition in concanavalin A protein. Journal of Molecular Liquids, 269, 796–804. doi: 10.1016/j.molliq.2018.08.092
   Web of Science ®Google Scholar
• Khan, J. M., Malik, A., Sen, P., Ahmed, A., Ahmed, M., Alamery, S. F., … Khan, M. I. (2019). Different conformational states of hen egg white lysozyme formed by exposure to the surfactant of sodium dodecyl benzenesulfonate. International Journal of Biological Macromolecules, 128, 54–60. doi: 10.1016/j.ijbiomac.2019.01.097
   PubMed Web of Science ®Google Scholar
• Khan, M. V., Zaman, M., Chandel, T. I., Siddiqui, M. K., Ajmal, M. R., Abdelhameed, A. S., & Khan, R. H. (2018). Cationic surfactant mediated fibrillogenesis in bovine liver catalase: A biophysical approach. Journal of Biomolecular Structure and Dynamics, 36(10), 2543–2557. doi: 10.1080/07391102.2017.1363085
   PubMed Web of Science ®Google Scholar
• Kumar, S., Harris, R. J., Seal, C. J., & Okello, E. J. (2012). An aqueous extract of Withania somnifera root inhibits amyloid β fibril formation in vitro. Phytotherapy Research, 26(1), 113–117. doi: 10.1002/ptr.3512
   PubMed Web of Science ®Google Scholar
• Kumar, S., Ravi, V. K., & Swaminathan, R. (2009). Suppression of lysozyme aggregation at alkaline pH by tri-N-acetylchitotriose. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1794(6), 913–920. doi: 10.1016/j.bbapap.2009.01.009
   PubMed Web of Science ®Google Scholar
• Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. The Journal of Neuroscience, 21(21), 8370–8377. doi: 10.1523/JNEUROSCI.21-21-08370.2001
   PubMed Web of Science ®Google Scholar
• Malki, A., Le, H.-T., Milles, S., Kern, R., Caldas, T., Abdallah, J., & Richarme, G. (2008). Solubilization of protein aggregates by the acid-stress chaperones HDEA and HDEB. Journal of Biological Chemistry, 208 (20), 13679–13687. doi: 10.1074/jbc.M800869200
   Google Scholar
• Mathew, M., & Subramanian, S. (2012). Evaluation of the anti-amyloidogenic potential of nootropic herbal extracts in vitro. International Journal of Pharmaceutical Sciences and Research, 3(11), 4276–4280. doi: 10.13040/IJPSR.0975-8232.
   Google Scholar
• McCammon, J. A., Gelin, B. R., Karplus, M., & Wolynes, P. G. (1976). The hinge-bending mode in lysozyme. Nature, 262(5566), 325.
   PubMed Web of Science ®Google Scholar
• McLaurin, J., Yang, D. S., Yip, C. M., & Fraser, P. E. (2000). Review: Modulating factors in amyloid-β fibril formation. Journal of Structural Biology, 130(2), 259–270. doi: 10.1006/jsbi.2000.4289
   PubMed Web of Science ®Google Scholar
• Mishra, R., Sörgjerd, K., Nyström, S., Nordigården, A., Yu, Y.-C., & Hammarström, P. (2007). Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. Journal of Molecular Biology, 366(3), 1029–1044. doi: 10.1016/j.jmb.2006.11.084
   PubMed Web of Science ®Google Scholar
• Morshedi, D., Rezaei-Ghaleh, N., Ebrahim-Habibi, A., Ahmadian, S., & Nemat-Gorgani, M. (2007). Inhibition of amyloid fibrillation of lysozyme by indole derivatives-Possible mechanism of action. FEBS Journal, 274(24), 6415–6425. doi: 10.1111/j.1742-4658.2007.06158.x
   PubMed Web of Science ®Google Scholar
• Pase, M. P., Kean, J., Sarris, J., Neale, C., Scholey, A. B., & Stough, C. (2012). The cognitive-enhancing effects of Bacopa monnieri: A systematic review of randomized, controlled human clinical trials. The Journal of Alternative and Complementary Medicine, 18(7), 647–652. doi: 10.1089/acm.2011.0367
   PubMed Web of Science ®Google Scholar
• Patel, P., Parmar, K., Patel, D., Kumar, S., Trivedi, M., & Das, M. (2018). Inhibition of amyloid fibril formation of lysozyme by ascorbic acid and a probable mechanism of action. International Journal of Biological Macromolecules, 114, 666–678. doi: 10.1016/j.ijbiomac.2018.03.152
   PubMed Web of Science ®Google Scholar
• Pepys, M., Hawkins, P., Booth, D., Vigushin, D., Tennent, G., Soutar, A., … Terry, C. (1993). Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature, 362(6420), 553. doi: 10.1038/362553a0
   PubMed Web of Science ®Google Scholar
• Prasanna, G., Hari, N., & Saraswathi, N. T. (2018). Hydroxy methoxy benzaldehyde from Sesbania grandilfora inhibits the advanced glycation end products (AGEs)-mediated fibrillation in hemoglobin. Journal of Biomolecular Structure and Dynamics, 36(4), 819–829. doi: 10.1080/07391102.2017.1300543
   PubMed Web of Science ®Google Scholar
• Prince, M., Wimo, A., Guerchet, M., Ali, G., Wu, Y., & Prina, M. (2015). The global impact of dementia. An analysis of prevalence, incidence, cost & trends (World Alzheimer Report 2015). London, UK: Alzheimer’s Disease International. World Health Organization. Available from: https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf.[Cited April 15, 2016]
   Google Scholar
• Rothwarf, D. M., & Scheraga, H. A. (1996). Role of non-native aromatic and hydrophobic interactions in the folding of hen egg white lysozyme. Biochemistry, 35(43), 13797–13807. doi: 10.1021/bi9608119
   PubMed Web of Science ®Google Scholar
• Roy, A. S., & Ghosh, P. (2016). Characterization of the binding of flavanone hesperetin with chicken egg lysozyme using spectroscopic techniques: Effect of pH on the binding. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 84(1–2), 21–34. doi: 10.1007/s10847-015-0578-8
   Web of Science ®Google Scholar
• Saini, N., Singh, D., & Sandhir, R. (2012). Neuroprotective effects of Bacopa monnieri in experimental model of dementia. Neurochemical Research, 37(9), 1928–1937. doi: 10.1007/s11064-012-0811-4
   PubMed Web of Science ®Google Scholar
• Sanjeev, A., & Mattaparthi, V. S. K. (2018). Computational investigation on the effects of H50Q and G51D mutations on the α-synuclein aggregation propensity. Journal of Biomolecular Structure and Dynamics, 36(9), 2224–2236. doi: 10.1080/07391102.2017.1347060
   PubMed Web of Science ®Google Scholar
• Save, S. N., & Choudhary, S. (2017). Effects of triphala and guggul aqueous extracts on inhibition of protein fibrillation and dissolution of preformed fibrils. RSC Advances, 7(33), 20460–20468. doi: 10.1039/C6RA28440J
   Web of Science ®Google Scholar
• Singh, H., & Dhawan, B. (1997). Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi.). Indian Journal of Pharmacology, 29(5), 359.
   Google Scholar
• Sivalingam, V., Prasanna, N. L., Sharma, N., Prasad, A., & Patel, B. K. (2016). Wild-type hen egg white lysozyme aggregation in vitro can form self-seeding amyloid conformational variants. Biophysical Chemistry, 219, 28–37. doi: 10.1016/j.bpc.2016.09.009
   PubMed Web of Science ®Google Scholar
• Stefani, M. (2012). Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer's disease and other diseases with amyloid deposits. Progress in Neurobiology, 99(3), 226–245. doi: 10.1016/j.pneurobio.2012.03.002
   PubMed Web of Science ®Google Scholar
• Swaminathan, R., Ravi, V. K., Kumar, S., Kumar, M. V. S., & Chandra, N. (2011). Lysozyme: A model protein for amyloid research. In R. Donev (Ed.), Advances in protein chemistry and structural biology (Vol. 84, pp. 63–111). Cambridge, MA: Academic Press.
   Google Scholar
• Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., … Hodgson, R. (2017). Protein misfolding in neurodegenerative diseases: Implications and strategies. Translational Neurodegeneration, 6, 6. doi: 10.1186/s40035-017-0077-5
   PubMed Web of Science ®Google Scholar
• Teichberg, V. I., & Sharon, N. (1970). A spectrofluorometric study of tryptophan 108 in hen egg‐white lysozyme. FEBS Letters, 7(2), 171–174. doi: 10.1016/0014-5793(70)80148-X
   PubMed Web of Science ®Google Scholar
• Trexler, A. J., & Nilsson, M. R. (2007). The formation of amyloid fibrils from proteins in the lysozyme family. Current Protein & Peptide Science, 8(6), 537–557. doi: 10.2174/138920307783018659
   PubMed Web of Science ®Google Scholar
• Uabundit, N., Wattanathorn, J., Mucimapura, S., & Ingkaninan, K. (2010). Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model. Journal of Ethnopharmacology, 127(1), 26–31. doi: 10.1016/j.jep.2009.09.056
   PubMed Web of Science ®Google Scholar
• Velander, P., Wu, L., Henderson, F., Zhang, S., Bevan, D. R., & Xu, B. (2017). Natural product-based amyloid inhibitors. Biochemical Pharmacology, 139, 40–55. doi: 10.1016/j.bcp.2017.04.004
   PubMed Web of Science ®Google Scholar
• Wong, Y. H., Lim, C. H., Kadir, H. A., & Tayyab, S. (2014). Towards increasing chemical and thermal stability of lysozyme with a simulated honey sugar cocktail. RSC Advances, 4(96), 53891–53898. doi: 10.1039/C4RA09606A
   Web of Science ®Google Scholar
• Zanforlin, E., Zagotto, G., & Ribaudo, G. (2017). An overview of new possible treatments of Alzheimer's disease, based on natural products and semi-synthetic compounds. Current Medicinal Chemistry, 24(34), 3749–3773. doi: 10.2174/0929867324666170712161829
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Kong, D. Y., Peng, L., & Zhang, W. D. (2009). A new triterpenoid saponin from Bacopa monniera. Chinese Chemical Letters, 20(5), 569–571. doi: 10.1016/j.cclet.2009.01.004
   Web of Science ®Google Scholar